CYTEK BIOSCIENCES, INC. Increase (Decrease) in Deferred Revenue
CYTEK BIOSCIENCES, INC. (CTKB) reported Increase (Decrease) in Deferred Revenue of $775.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was -$400.00K, a 268.07% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $1.18M, a 12.51% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was $1.74M, a 24.62% increase year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $284.00K, a 83.88% decline year-over-year.
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2025 was $3.60M, a 3.64% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2024 was $3.74M, a 42.68% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2023 was $6.52M, a 30.72% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2022 was $9.41M, a 6.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $775.00K 10-Q · filed 2026-08-05 | $2.51M derived: sum of 3 quarters · filed 2026-08-05 | $2.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.18M 10-Q · filed 2026-05-07 | $2.91M derived: sum of 2 quarters · filed 2026-05-07 | $3.19M derived: sum of 3 quarters · filed 2026-05-07 | $3.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.02M derived: sum of 2 quarters · filed 2026-02-26 | $2.26M derived: sum of 3 quarters · filed 2026-08-05 | $3.60M 10-K · filed 2026-02-26 |
| 2025-09-30 | $284.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $522.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.86M 10-Q · filed 2025-11-05 | $3.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.58M 10-Q · filed 2026-08-05 | $2.97M derived: sum of 3 quarters · filed 2026-08-05 | $4.74M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.34M 10-Q · filed 2026-05-07 | $2.74M derived: sum of 2 quarters · filed 2026-05-07 | $4.50M derived: sum of 3 quarters · filed 2026-05-07 | $4.54M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.15M derived: sum of 2 quarters · filed 2026-02-26 | $3.19M derived: sum of 3 quarters · filed 2026-02-26 | $3.74M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.80M derived: sum of 2 quarters · filed 2025-11-05 | $2.34M 10-Q · filed 2025-11-05 | $1.65M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $582.00K 10-Q · filed 2025-08-06 | -$114.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.38M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $542.00K 10-Q · filed 2025-05-08 | -$154.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.34M derived: sum of 3 quarters · filed 2026-02-26 | $7.11M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $799.00K derived: sum of 2 quarters · filed 2026-02-26 | $6.57M derived: sum of 3 quarters · filed 2026-02-26 | $6.52M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $7.26M derived: sum of 2 quarters · filed 2024-11-07 | $7.22M 10-Q · filed 2024-11-07 | $10.13M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $5.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $5.72M 10-Q · filed 2024-08-06 | $8.64M derived: sum of 3 quarters · filed 2025-02-28 | $10.53M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$49.00K 10-Q · filed 2024-05-08 | $2.87M derived: sum of 2 quarters · filed 2025-02-28 | $4.76M derived: sum of 3 quarters · filed 2025-02-28 | $6.78M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.81M derived: sum of 2 quarters · filed 2025-02-28 | $6.83M derived: sum of 3 quarters · filed 2025-02-28 | $9.41M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.92M derived: sum of 2 quarters · filed 2023-11-14 | $6.50M 10-Q · filed 2023-11-14 | $9.87M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.60M 10-Q · filed 2023-08-08 | $7.97M derived: sum of 3 quarters · filed 2024-03-13 | $10.69M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $2.58M 10-Q · filed 2023-05-09 | $5.96M derived: sum of 2 quarters · filed 2024-03-13 | $8.67M derived: sum of 3 quarters · filed 2024-03-13 | $10.86M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $6.09M derived: sum of 2 quarters · filed 2024-03-13 | $8.28M derived: sum of 3 quarters · filed 2024-03-13 | $10.01M 10-K · filed 2024-03-13 |
| 2021-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.90M derived: sum of 2 quarters · filed 2022-11-09 | $6.64M 10-Q · filed 2022-11-09 | $7.88M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $3.92M 10-Q · filed 2022-08-10 | $5.16M derived: sum of 3 quarters · filed 2023-03-01 | $5.48M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $1.74M 10-Q · filed 2022-05-12 | $2.98M derived: sum of 2 quarters · filed 2023-03-01 | $3.30M derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.56M derived: sum of 2 quarters · filed 2023-03-01 | $2.38M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.14M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $818.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |